APRN 25Hr pharmacology package

This continuing education package is designed for satisfying the pharmacology continuing education requirement for advanced practice providers for board certification renewals. The package is created with carefully chosen topics that address a wide variety of specialties and practices. This is a customized and discounted package where candidates can easily obtain the required hours without the hassle of taking lengthy exams. The entire course is streamlined to be finished with least time as possible. The certificates are readily available for download after completion of a 50-question posttest and reflective evaluation form.


APRN pharmacology 25 hr package

$99.00.

SUBSCRIBE NOW

For 1 Year.

Antiarrhythmic Agents – Overview

Ventricular arrhythmias, including ventricular fibrillation (VF) and sustained ventricular tachycard...

Stroke – Antiplatelet Recommendation

Stroke is one of the leading causes of disability and death. Ischemic stroke is a syndrome with hete...

Thienopyridines and Ticagrelor

Coronary artery disease (CAD) and acute coronary syndrome (ACS) are leading causes of mortality in t...

Genetic Variants and Antiplatelet Efficacy

In recent years, substantial effort has been made to better understand the influence of genetic fact...

Newest Pharmacologic Agents for Management of COPD

Chronic obstructive pulmonary disease (COPD) is associated with high morbidity and mortality. COPD i...

Systemic vs. Inhaled Steroids – Efficacy and Side Effect Profile

Systemic and local inflammation is central to the pathophysiology of chronic obstructive pulmonary d...

Safety and Efficacy of New Oral Anticoagulant Agents – What We Know Now

Oral anticoagulants are highly effective for stroke prevention in patients with atrial fibrillation,...

Provider Perspective in Choosing Long-term Anticoagulation Agents

Anticoagulants are used in several other situations by practicing neurologists, including cervical a...

Afib – Updated Management Strategies-duplicate-1

Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and morta...

Mechanism of PCSK 9 Inhibitors and Clinical Utility

Reducing plasma levels of low-density lipoprotein cholesterol (LDL-C) remains the cornerstone in the...

Related Courses